Ensign Peak Advisors, Inc Roivant Sciences Ltd. Transaction History
Ensign Peak Advisors, Inc
- $56.1 Billion
- Q3 2024
A detailed history of Ensign Peak Advisors, Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 118,378 shares of ROIV stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,378
Previous 118,378
-0.0%
Holding current value
$1.32 Million
Previous $1.25 Million
9.19%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
316Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$736 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$734 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$604 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$465 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$395 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.86B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...